Mohedas, A., Wang, Y., Sanvitale, C., Canning, P., Choi, S., Xing, X., . . . Yu, P. (2014). Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.
Citace podle Chicago (17th ed.)Mohedas, A., Y. Wang, C. Sanvitale, P. Canning, S. Choi, X. Xing, A. Bullock, G. Cuny, a P. Yu. Structure-activity Relationship of 3,5-diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. 2014.
Citace podle MLA (9th ed.)Mohedas, A., et al. Structure-activity Relationship of 3,5-diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. 2014.